The Scrutiny on Skin Substitutes: Shifting The Focus From Medicare Advantage

Jan 1, 2025
The Scrutiny on Skin Substitutes: Shifting The Focus From Medicare Advantage

While the top six major insurance companies have reported soaring profits—some rising by thousands of percentage points since the Medicare Advantage program was enacted, many patients enrolled in Medicare Advantage plans claim they didn’t even realize they were leaving traditional Medicare. This lack of transparency raises important questions about how these plans are marketed and the tactics used to encourage patients to switch.

Have you ever wondered why there is so much scrutiny on the use of skin substitutes to treat chronic wounds of Medicare patients? Is it purely coincidental that at the same time so much emphasis is being placed on how the wound care industry is regulated, Medicare Advantage enrollment has surged, outpacing traditional Medicare in many states? It’s interesting to note that OIG posted this late night on Wednesday night, and nobody even noticed because everybody is so focused on defending a small part of the Medicare expenditures – skin substitutes.

While the top six major insurance companies have reported soaring profits—some rising by thousands of percentage points since the Medicare Advantage program was enacted, many patients enrolled in Medicare Advantage plans claim they didn’t even realize they were leaving traditional Medicare. This lack of transparency raises important questions about how these plans are marketed and the tactics used to encourage patients to switch.

Representatives of the wound care industry aren’t even allowed to leave a pen in a provider’s office, while insurance companies have been providing nice incentives for to switch patients to Med Advantage or allegedly to allow agents of Med Advantage insurers access to their patient data to have their agents “encourage” patients to switch.  

This is particularly concerning when these recommendations may not be in the patient’s best interest. Many patients are unaware they’re opting out of the flexibility and breadth of coverage provided by traditional Medicare. As a result, those with higher health expenditure needs may find themselves facing unexpected expenses or coverage limitations down the line.  


Right now, we’re in the midst of Medicare’s open enrollment period—an ideal time to scrutinize the choices at hand. Providers should talk openly with their patients about the differences between Medicare Advantage and traditional Medicare. Specifically, if a patient is going to need expensive treatments not covered under a National Coverage Determination (NCD), like skin substitutes, or treatments that are covered, but under extremely restrictive policies determined by the MACs.  Patients (and their loved ones), in turn, should carefully research their options, ask tough questions, and avoid being swayed by enticing phone calls or marketing materials alone and ask instead, “What will my giving up traditional Medicare mean for me in terms of denied treatments that may be needed?”  

Key Takeaways for Patients & Their Families:

Ask Questions: Before signing up for Medicare Advantage, find out how it compares to traditional Medicare in terms of network restrictions, out-of-pocket costs, and coverage for specialized products and services, especially the care you may need.  

Stay Informed: Recognize that the aggressive push towards Medicare Advantage is motivated by profit.  Seek multiple sources of information—speak with trusted healthcare providers, read reputable articles, and consider consulting a Medicare counselor or benefits advisor who is not ultimately paid by insurers.  

Think Long-Term: If you anticipate higher healthcare expenditures in the future, remember that Medicare Advantage plans sometimes come with limits and may result in higher out-of-pocket costs for certain treatments or procedures.

Ultimately, understanding the forces behind Medicare Advantage’s growth and the potential consequences of enrolling in these plans is crucial. With the right information and guidance, patients and their families can make more informed decisions—ones that prioritize health, coverage, and financial well-being over insurance industry profits.

More News & Updates

Stay Up-To-Date With
Venture Medical

Mar 11, 2025

Open Wound Research and Venture Medical Announce Collaboration to Advance Pressure Ulcer Research

Feb 12, 2025

Innovation & Adaptability: An Interview with the CEO of Venture Medical,LLC

In an industry where innovation and adaptability are key, Venture Medical, LLC has carved out a unique space, blending bold ambition with a steadfast commitment to quality and service. Over the past few years, the company has experienced exponential growth, but what truly sets Venture apart isn’t just its expansion—it’s the culture, leadership philosophy, and relentless pursuit of excellence that fuel its success.

Jan 15, 2025

The LCD Is Frozen, Now What?

On Monday during his first day in office, President Trump signed an Executive Order (EO) freezing the pending LCD policy that would limit access to skin substitutes for chronic wound care. To be clear - this is a policy freeze pending further action.

Oct 28, 2024

Venture Medical announced as the exclusive US distributor of Vendaje AC ®

Venture Medical, LLC has been announced as the exclusive distributor of Vendaje AC®, a wound care product manufactured by BioStem Technologies Inc. (OTC: BSEM).

Oct 21, 2024

The Rising Costs of Wound Care: Finding Solutions Without Sacrificing Access

Under a system previously reliant solely on hospital outpatient departments, many patients—especially the elderly in care facilities, the poor, the homebound, the rural, and the otherwise disenfranchised—never enjoyed equitable access. Today, however, more patients than ever are receiving wound care as providers are motivated to bring advanced modalities directly to them.

Jan 24, 2024

MicroGen Diagnostics in Chronic Wounds

“Explore the fascinating realm of microbiology and healthcare in the MicroGenDX Mic’d Up podcast, hosted by Rick Martin, CEO of MicroGenDX. Join Rick and his special guest, the esteemed Caroline Fife, MD, FAAFP, CWS, Professor of Medicine at Baylor College of Medicine

Dec 14, 2023

Center for Medicare Services Established National Pricing of AmnioWrap2™ in All MAC Regions

The national ASP publication of AmnioWrap2™ knocks down barriers that will provide healthcare professionals and their patients with the opportunity to use AmnioWrap2™, a superior wound care product for certain applications.

Sep 7, 2022

The Gap Between Clinical Trials and Real-World Chronic Wound Patients

Caroline Fife, M.D. highlights a concerning discrepancy between the characteristics of patients with chronic wounds in real-world settings and those selected for clinical trials.

Sep 1, 2022

Demonstration of the Venture Medical Sacral Dressing Kit

Get a first-hand look at the application process of the Venture Medical Sacral Dressing Kit in this short video. We illustrate the kit's key role in protecting wounds from contaminants for patients with pressure ulcers who also suffer from incontinence. The demonstration also highlights how this kit supports the performance of advanced treatments such as CTPs. Learn to enhance your wound care practices and promote better wound healing with this cutting-edge solution.